Biohaven - Federal Court Confirms Ra Capital And Avilar Therapeutics "Misappropriated" Yale Trade Secret - BHVN News | RalliesBiohaven - Federal Court Confirms Ra Capital And Avilar Therapeutics "Misappropriated" Yale Trade Secret
B
BHVN• Federal court confirms trade secret misappropriation
- Biohaven Ltd. BHVN.N said a federal court confirmed that Ra Capital and Avilar Therapeutics "misappropriated" a Yale trade secret.
- The U.S. District Court awarded $4 million to Biohaven and Yale in the trade secret case.
•
